Occult hepatitis B infections among blood donors in Lao PDR

Vox Sanguinis

Volumn 106, Issue 1, 2014, Pages 31-37

  Jutavijittum, P ^a   Andernach, I E ^b   Yousukh, A ^a   Samountry, B ^c   Samountry, K ^c   Thammavong, T ^d   Keokhamphue, J ^d   Toriyama, K ^e   Muller, C P ^b,f  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^c UNIVERSITY OF HEALTH SCIENCES   (Laos)

^d National Blood Transfusion Center   (Laos)

^e Japanese Red Cross Nagasaki Atomic Bomb Hospital Nagasaki   (Japan)

^f Institut Pasteur du Laos   (Laos)

Author keywords

Chronic hepatitis B infection; Hepatitis B virus; Occult hepatitis B infection; Seroclearance; Serological markers

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; FEMALE; GENE DOSAGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LAOS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT SAFETY; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION; YOUNG ADULT;

CHRONIC HEPATITIS B INFECTION; HEPATITIS B VIRUS; OCCULT HEPATITIS B INFECTION; SEROCLEARANCE; SEROLOGICAL MARKERS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD DONORS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LAOS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; YOUNG ADULT;

EID: 84890794830     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12073     Document Type: Article

References (30)

1. Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11:97-107
2. WHO: Hepatitis B fact sheet. 2000
3. Liaw YF, Leung N, Kao JH, et al.: Chronic Hepatitis BGWPotA-PAftSotL: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hep Intl 2008; 2:263-283
4. Candotti D, Danso K, Allain JP: Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol 2007; 88:2686-2695
5. Raimondo G, Allain JP, Brunetto MR, et al.: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49:652-657
6. Liu CJ, Chen DS, Chen PJ: Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006; 36(Suppl. 1):S33-S44
7. Ocana S, Casas ML, Buhigas I, et al.: Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 2011; 17:1553-1557
8. Alavian SM, Miri SM, Hollinger FB, et al.: Occult Hepatitis B (OHB) in Clinical Settings. Hepat Mon 2012; 12:e6126.
9. Candotti D, Allain JP: Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009; 51:798-809
10. Ol HS, Bjoerkvoll B, Sothy S, et al.: Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia. Southeast Asian J Trop Med Public Health 2009; 40:963-971
11. Phikulsod S, Oota S, Tirawatnapong T, et al.: Working Group for NATSiTBD: One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009; 49:1126-1135
12. Jutavijittum P, Yousukh A, Samountry B, et al.: Seroprevalence of hepatitis B and C virus infections among Lao blood donors. Southeast Asian J Trop Med Public Health 2007; 38:674-679
13. Olinger CM, Venard V, Njayou M, et al.: Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 2006; 87:1163-1173
14. Tamura K, Peterson D, Peterson N, et al.: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28:2731-2739
15. Liu Y, Hussain M, Wong S, et al.: A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA. J Clin Microbiol 2007; 45:553-558
16. Chu CM, Liaw YF: Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepatitis 2007; 14:147-152
17. Andernach IE, Jutavijittum P, Samountry B, et al.: A high variability of mixed infections and recent recombinations of hepatitis B virus in Laos. PLoS ONE 2012; 7:e30245
18. Kao JH, Chen PJ, Lai MY, et al.: Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 2004; 72:363-369
19. Yuen MF, Sablon E, Tanaka Y, et al.: Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 2004; 41:119-125
20. Thedja MD, Roni M, Harahap AR, et al.: Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int 2010; 4:608-614
21. Panigrahi R, Biswas A, Datta S, et al.: Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J 2010; 7:204
22. Kleinman SH, Kuhns MC, Todd DS, et al.: Retrovirus Epidemiology Donor S: Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43:696-704
23. Yuan Q, Ou SH, Chen CR, et al.: Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 2010; 48:357-362
24. Candotti D, Lin CK, Belkhiri D, et al.: Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut 2012; 61:1744-1753
25. Torbenson M, Thomas DL: Occult hepatitis B. Lancet Infect Dis 2002; 2:479-486
26. Chimparlee N, Oota S, Phikulsod S, et al.: Hepatitis B and hepatitis C virus in Thai blood donors. Southeast Asian J Trop Med Public Health, 2011; 42:609-615
27. Louisirirotchanakul S, Oota S, Khuponsarb K, et al.: Working Group for NATSiTBD: Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011; 51:1532-1540
28. Wang JT, Lee CZ, Chen PJ, et al.: Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002; 42:1592-1597.
29. Satake M, Taira R, Yugi H, et al.: Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47:1197-1205
30. Allain JP, Mihaljevic I, Gonzalez-Fraile MI, et al.: Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion 2013; 7:1405-1415